We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Trends in Laparoscopic Colorectal Tumor Resections

By HospiMedica International staff writers
Posted on 22 Oct 2009
The number of patients in England that undergo laparoscopic resection of colorectal cancer has increased fifteen-fold in just ten years, according to a new study.

Researchers at the University of Leeds (United Kingdom) collected information on all patients who underwent a major resection for colorectal cancer between 1998 and 2006 from the U.K. More...
National Cancer Data Repository. Analyses were undertaken to determine the frequency of use of laparoscopic surgery across the country as well as patient characteristics that included age, sex, socioeconomic status, tumor stage that could have affected the likelihood of receiving laparoscopic surgery; 30-day operative mortality and duration of hospital stay of patients receiving open and laparoscopic surgery were also compared.

The researchers found that of 160,817 major colorectal cancer resections performed between 1998 and 2006, 3,460 (2.2%) were performed laparoscopically. Over time, there was a significant increase in the number of laparoscopic operations being performed with numbers rising from 98 (0.6%) in 1998 to 1,459 (7.8%) in 2006. Multivariate analysis indicated women were more likely to receive laparoscopic surgery than men, while patients with rectal tumors, advanced Dukes' stages, and comorbidities were less likely to be treated laparoscopically. Patients receiving laparoscopic surgery were also less likely to die within 30 days of the operation, and had shorter hospital stays. The study was presented at the National Cancer Research Institute (NCRI, London, United Kingdom) cancer conference, held during October 2009 in Birmingham (UK).

"Our results are encouraging. Just a decade after the technique was introduced, fifteen times more people with bowel cancer are now benefiting,” said lead author and study presenter Eva Morris, M.D. "It's essential with these new and exciting techniques that surgeons are trained quickly, and our figures show that the national training program for this particular type of surgery has been successful so far. The technique is, however, relatively new so it's important that its outcomes are monitored.”

In August 2006, the U.K. National Institute for Health and Clinical Excellence (NICE; London, UK) issued guidance approving laparoscopic bowel surgery as a possible alternative to traditional open surgery for people with bowel cancer. The U.K. National Health Service (NHS) aims to offer this procedure in all hospitals in the United Kingdom by 2012.

Related Links:

University of Leeds
National Cancer Research Institute
National Institute for Health and Clinical Excellence



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.